Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Most adult females with acne do not have hormonal imbalances, but some show signs of excess male hormones.

Finasteride doesn't affect hormone levels in normal men.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

PCOS has many symptoms, with high androgen levels being the most common.

High doses of finasteride cause cell growth and tumors in mice.

Finasteride causes abnormal growth in male mice cells at high doses.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.